FDA Inspection 772742 — GlaxoWellcome Production
The FDA completed an inspection of GlaxoWellcome Production on Feb 27, 2012 in Evreux. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 27, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Evreux (France)